Increased Levels of Rivaroxaban in Patients After Liver Transplantation Treated With Cyclosporine A

被引：32

作者：

Wannhoff, Andreas ^{[1
]}

Weiss, Karl H. ^{[1
]}

Schemmer, Peter ^{[2
]}

Stremmel, Wolfgang ^{[1
]}

Gotthardt, Daniel N. ^{[1
]}

机构：

[1] Univ Heidelberg Hosp, Dept Internal Med 4, D-69120 Heidelberg, Germany

[2] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, D-69120 Heidelberg, Germany

来源：

TRANSPLANTATION | 2014年 / 98卷 / 02期

关键词：

PREVENTION;

D O I：

10.1097/TP.0000000000000223

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E12 / E13

页数：2

共 5 条

[1]

European Medicines Agency, XAR EPAR PROD INF

[2] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment [J].

Fox, Keith A. A. ;

Piccini, Jonathan P. ;

Wojdyla, Daniel ;

Becker, Richard C. ;

Halperin, Jonathan L. ;

Nessel, Christopher C. ;

Paolini, John F. ;

Hankey, Graeme J. ;

Mahaffey, Kenneth W. ;

Patel, Manesh R. ;

Singer, Daniel E. ;

Califf, Robert M. .

EUROPEAN HEART JOURNAL, 2011, 32 (19) :2387-2394

[3] CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus [J].

Lemahieu, WPD ;

Maes, BD ;

Verbeke, K ;

Vanrenterghem, Y .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (09) :1514-1522

[4] Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement [J].

Mueck, Wolfgang ;

Borris, Lars C. ;

Dahl, Ola E. ;

Haas, Sylvia ;

Huisman, MennoV. ;

Kakkar, Ajay K. ;

Kalebo, Peter ;

Muelhofer, Eva ;

Misselwitz, Frank ;

Eriksson, Bengt I. .

THROMBOSIS AND HAEMOSTASIS, 2008, 100 (03) :453-461

[5] Laboratory assessment of rivaroxaban: A review [J].

Samama M.M. ;

Contant G. ;

Spiro T.E. ;

Perzborn E. ;

Le Flem L. ;

Guinet C. ;

Gourmelin Y. ;

Rohde G. ;

Martinoli J.-L. .

Thrombosis Journal, 11 (1)

← 1 →